The Journal of Practical Medicine >
Analysis of influence of demodex infection on clinical symptoms， signs and content of MMP⁃9 in tears of patients with meibomian gland dysfunction
Received date: 2024-12-26
Online published: 2025-04-23
Objective To investigate the effects of Demodex infection on clinical symptoms， signs， and tear MMP?9 levels in patients with meibomian gland dysfunction （MGD）. Methods A total of 680 patients with MGD were selected from our hospital， including 162 males and 518 females， with an average age of （45.05 ± 15.41） years old. The patients were divided into two groups based on the presence of Demodex mite infestation： the Demodex positive group （340 cases） and the Demodex negative group （340 cases）. All patients underwent evaluations using the OSDI questionnaire， SPEED questionnaire， eyelid margin alteration score， corneal fluorescein staining score， tear MMP?9 measurement， meibomian gland orifice score， meibomian gland excretion ability score， meibomian gland secretion score， meibomian gland loss score， tear film breakup time （BUT）， and Schirmer I tear secretion test. The differences in these indicators between the two groups were compared. Results SPEED questionnaire score： Demodex positive group： （7.68 ± 2.80）， Demodex negative group： （6.28 ± 1.99）. There was a statistically significant difference between the two groups （t = 2.582， P = 0.012）. Eyelid margin alteration score： Demodex positive group： （3.63 ± 1.53）， Demodex negative group： （2.85 ± 0.77）. A statistically significant difference was observed （t = 2.861， P = 0.006）. Corneal fluorescein staining score： Demodex positive group： （2.25 ± 1.86）， Demodex negative group： （1.08 ± 1.33）. There was a statistically significant difference （t = 3.247， P = 0.002）. Tear MMP?9 content： Demodex positive group： （30.76 ± 43.14） ng/mL， Demodex negative group： （12.36 ± 12.10） ng/mL. A statistically significant difference was found （t = 2.598， P = 0.013）. No statistically significant differences were observed between the Demodex positive and negative groups in meibomian gland orifice score， meibomian gland excretion ability score， meibomian gland secretion score， meibomian gland loss score， BUT， tear secretion examination， and age comparison （P > 0.05）. Conclusions Demodex mite infestation in patients with MGD exhibits significant differences across various clinical indicators， notably in SPEED questionnaire scores， eyelid margin alterations， corneal fluorescein staining， and tear MMP?9 levels. These changes are associated with mechanisms including inflammatory responses， cellular damage， and immune dysregulation. Demodex mite infestation may significantly influence the clinical progression of MGD by exacerbating inflammation and symptom severity， potentially playing a crucial role in disease development.
Shujin WEI , Jinrong ZHAO , Yuanlong ZHANG , Wenjuan CHU , Dan SHEN , Weiyi HUANG , Lu TIAN . Analysis of influence of demodex infection on clinical symptoms， signs and content of MMP⁃9 in tears of patients with meibomian gland dysfunction[J]. The Journal of Practical Medicine, 2025 , 41(7) : 997 -1003 . DOI: 10.3969/j.issn.1006-5725.2025.07.010
| 1 | CHATTERJEE S， AGRAWAL D， SANOWAR G， et al. Prevalence of symptoms of dry eye disease in an urban Indian population［J］. Indian J Ophthalmol， 2021， 69（5）：1061-1066. doi:10.4103/ijo.ijo_1796_20 |
| 2 | PAPAS E B. The global prevalence of dry eye disease： A Bayesian view［J］. Ophthalmic Physiol Opt， 2021， 41（6）：1254-1266. doi:10.1111/opo.12888 |
| 3 | 亚洲干眼协会中国分会，海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组，中国医师协会眼科医师分会眼表与干眼学组. 中国睑板腺功能障碍专家共识：定义和分类（2023年）［J］. 中华眼科杂志，2023，59（4）：256-261. |
| 4 | CHAN T C Y， CHOW S S W， WAN K H N， et al. Update on the association between dry eye disease and meibomian gland dysfunction［J］. Hong Kong Med J， 2019， 25（1）：38-47. |
| 5 | SABETI S， KHEIRKHAH A， YIN J， et al. Management of meibomian gland dysfunction： a review［J］. Surv Ophthalmol， 2020， 65（2）：205-217. doi:10.1016/j.survophthal.2019.08.007 |
| 6 | MOON S Y， HAN S A， KWON H J， et al. Effects of lid debris debridement combined with meibomian gland expression on the ocular surface MMP-9 levels and clinical outcomes in moderate and severe meibomian gland dysfunction［J］. BMC Ophthalmol， 2021， 21（1）：175-183. doi:10.1186/s12886-021-01926-2 |
| 7 | 亚洲干眼协会中国分会，海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组，中国医师协会眼科医师分会眼表与干眼学组. 中国睑板腺功能障碍专家共识：诊断和治疗（2023年）［J］. 中华眼科杂志，2023，59（11）：880-887. |
| 8 | HANLON K， THOMLEY M， CORREA-SELM L. In Vivo View of a Reclining Demodex Mite in a Milia Cyst［J］. Diagnostics （Basel）， 2023，13（10）：1718-1719. doi:10.3390/diagnostics13101718 |
| 9 | ZHU D， GUPTA R R， STEIN R L， et al. Randomized Prospective Evaluation of Microblepharoexfoliation BlephEx as Adjunctive Therapy in the Treatment of Chalazia［J］. Cornea， 2023， 42（2）：172-175. doi:10.1097/ico.0000000000003090 |
| 10 | 亚洲干眼协会中国分会，海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组，中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识：检查和诊断（2020年）［J］. 中华眼科杂志，2020，56（10）：741-747. |
| 11 | CAMELI N， MARIANO M， ZANNIELLO R， et al. Clinical and noninvasive instrumental evaluation of the efficacy of a nonsteroidal anti-inflammatory 8-beta glycyrrhetinic acid cream for the treatment of erythema in rosacea［J］. Dermatol Ther， 2020， 33（6）：e14224-14227. doi:10.1111/dth.14224 |
| 12 | JEON Y Y， BAE S， CHUNG H S， et al. Effects of combined intense pulsed light and cyclosporine 0.05% eyedrops in ocular surface matrix metalloproteinase-9 levels in patients with moderate-to-severe MGD［J］. Lasers Med Sci， 2024， 39（1）：203. doi:10.1007/s10103-024-04154-4 |
| 13 | YAN Y， YAO Q， LU Y， SHAO C， et al. Association Between Demodex Infestation and Ocular Surface Microbiota in Patients With Demodex Blepharitis［J］. Front Med， 2020， 7：592759-592767. doi:10.3389/fmed.2020.592759 |
| 14 | MCMAHON F W， GALLAGHER C， O'REILLY N， et al. Exposure of a corneal epithelial cell line （hTCEpi） to Demodex-associated Bacillus proteins results in an inflammatory response［J］. Invest Ophthalmol Vis Sci， 2014， 55（10）：7019-7028. doi:10.1167/iovs.14-15018 |
| 15 | HUNG K H， LAN Y H， LIN J Y， et al. Potential Role and Significance of Ocular Demodicosis in Patients with Concomitant Refractory Herpetic Keratitis［J］. Clin Ophthalmol， 2020， 14：4469-4482. doi:10.2147/opth.s282059 |
| 16 | 曹时燕，陈源，赵燕，等. 润房镜联合普拉洛芬滴眼液治疗干眼症的效果及对血清MMP-2、STRA6水平的影响［J］. 实用医学杂志，2019，35（3）：449-451. |
| 17 | ZAREH H， SHAHRIARY A， RAZEI A， et al. Doxycycline versus Curcumin for Inhibition of Matrix Metalloproteinase Expression and Activity Following Chemically Induced Inflammation in Corneal Cells［J］. J Ophthalmic Vis Res， 2024， 19（3）：273-283. doi:10.18502/jovr.v19i3.13689 |
| 18 | SHOARI A， KANAVI M R， RASAEE M J. Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome； a review study［J］. Exp Eye Res， 2021， 205：108523-108528. doi:10.1016/j.exer.2021.108523 |
| 19 | FORTON F M N. The Pathogenic Role of Demodex Mites in Rosacea： A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea？［J］. Dermatol Ther （Heidelb）， 2020， 10（6）：1229-1253. doi:10.1007/s13555-020-00458-9 |
| 20 | KIM J H， CHUN Y S， KIM J C. Clinical and immunological responses in ocular demodecosis［J］. J Korean Med Sci， 2011， 26（9）： 1231-1237. doi:10.3346/jkms.2011.26.9.1231 |
| 21 | KIM J T， LEE S H， CHUN Y S， et al. Tear cytokines and chemokines in patients with Demodex blepharitis［J］. Cytokine， 2011， 53（1）：94-99. doi:10.1016/j.cyto.2010.08.009 |
| 22 | SOMAN S P， SINGH S K， KUMARI P， et al. Quantification of immuno-regulatory cytokine and toll-like receptors gene expression in dogs with generalized demodicosis［J］. Vet Parasitol， 2020， 280：109063-109067. doi:10.1016/j.vetpar.2020.109063 |
| 23 | LACEY N， RUSSELL-HALLINAN A， ZOUBOULIS C C， et al. Demodex mites modulate sebocyte immune reaction： possible role in the pathogenesis of rosacea［J］. Br J Dermatol， 2018， 179（2）：420-430. |
/
| 〈 |
|
〉 |